Tobin Schilke

Chief Financial & Infra. Ofcr.; Chief Financial Officer · 4 filings · Latest: Sep 1, 2026

Crinetics Pharmaceuticals, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
CRNX	Tobin Schilke	Chief Financial Officer	Mar 3, 2026	Sale	$39.67	6,713	$266.3K	78,121	Mar 4 10:43 PM
CRNX	Tobin Schilke	—	Mar 2, 2026	Proposed Sale	$41.18	6,800	$280.0K	—	Mar 2 3:28 PM